Among the operational reasons that led to the company’s market entry in India deemed a failure was the name, Lucky Goldstar.

AstraZeneca and Amgen's TEZSPIRE® (tezepelumab -ekko) has been approved in the US for the add-on maintenance treatment of adult and pediatric patients aged 12 years and older with inadequately ...

The first round of EVM (Electronic Voting Machine) randomisation for the upcoming Dampa Assembly constituency bye-election has been successfully completed, marking <br />a significant step towards ...

Exclusive Discount Inside!: Between 2025 and 2030, the industrial RO skids market is expected to grow from USD 4,200.0 ...